Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Hong Zou, Li Li, Ines Garcia Carcedo, Zhi Ping Xu, Michael Monteiro & Wenyi Gu. (2016) Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis. International Journal of Nanomedicine 11, pages 1947-1958.
Read now
Read now
Jiezhong Chen, Renfu Shao, Li Li, Zhi Ping Xu & Wenyi Gu. (2014) Effective inhibition of colon cancer cell growth with MgAl-layered double hydroxide (LDH) loaded 5-FU and PI3K/mTOR dual inhibitor BEZ-235 through apoptotic pathways. International Journal of Nanomedicine 9, pages 3403-3411.
Read now
Read now
Mikhail V. Blagosklonny. (2012) Rapalogs in cancer prevention. Cancer Biology & Therapy 13:14, pages 1349-1354.
Read now
Read now
Articles from other publishers (25)
Åsmund Flobak, John Zobolas, Miguel Vazquez, Tonje S. Steigedal, Liv Thommesen, Asle Grislingås, Barbara Niederdorfer, Evelina Folkesson & Martin Kuiper. (2023) Fine tuning a logical model of cancer cells to predict drug synergies: combining manual curation and automated parameterization. Frontiers in Systems Biology 3.
Crossref
Crossref
Lyla J. Stanland, Hazel X. Ang, Jacob P. Hoj, Yunqiang Chu, Patrick Tan, Kris C. Wood & Micah A. Luftig. (2023)
CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in
PIK3CA
-Mutant Gastric Cancer
. Molecular Cancer Research 21:11, pages 1148-1162.
Crossref
Crossref
Elham Patrad, Solmaz Khalighfard, Taghi Amiriani, Vahid Khori & Ali Mohammad Alizadeh. (2022) Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy. Cellular Oncology 45:6, pages 1073-1117.
Crossref
Crossref
Omer H. M. Ibrahim, Kamal A. M. Abo-Elyousr, Khalid A. Asiry, Nabil A. Alhakamy & Magdi A. A. Mousa. (2022) Phytochemical Characterization, Antimicrobial Activity and In Vitro Antiproliferative Potential of Alchemilla vulgaris Auct Root Extract against Prostate (PC-3), Breast (MCF-7) and Colorectal Adenocarcinoma (Caco-2) Cancer Cell Lines. Plants 11:16, pages 2140.
Crossref
Crossref
Omer H. M. Ibrahim, Magdi A. A. Mousa, Khalid A. Asiry, Nabil A. Alhakamy & Kamal A. M. Abo-Elyousr. (2022) Azadirachta indica A. Juss Fruit Mesocarp and Epicarp Extracts Induce Antimicrobial and Antiproliferative Effects against Prostate (PC-3), Breast (MCF-7), and Colorectal Adenocarcinoma (Caco-2) Cancer Cell Lines through Upregulation of Proapoptotic Genes. Plants 11:15, pages 1990.
Crossref
Crossref
Ramasamy Selvarani, Sabira Mohammed & Arlan Richardson. (2020) Effect of rapamycin on aging and age-related diseases—past and future. GeroScience 43:3, pages 1135-1158.
Crossref
Crossref
Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri-Sigaroodi, Ali Pirsalehi, Ava Safaroghli-azar, Mohammad Reza Zali & Davood Bashash. (2021) The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions. European Journal of Pharmacology 898, pages 173983.
Crossref
Crossref
Bhaskar Bhattacharya, Daniel Q. Huang, Sarah Hong Hui Low, Gim Hwa Tan, Min Ji Han, Sanamerjit Singh, Benny Tang, Sheng Chun Chang, Joey Sze Yun Lim, Mohd Feroz Mohd Omar, Yock Young Dan & Richie Soong. (2021) Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells. Oncotarget 12:7, pages 674-685.
Crossref
Crossref
Jin-Ku Lee, Zhaoqi Liu, Jason K. Sa, Sang Shin, Jiguang Wang, Mykola Bordyuh, Hee Jin Cho, Oliver Elliott, Timothy Chu, Seung Won Choi, Daniel I. S. Rosenbloom, In-Hee Lee, Yong Jae Shin, Hyun Ju Kang, Donggeon Kim, Sun Young Kim, Moon-Hee Sim, Jusun Kim, Taehyang Lee, Yun Jee Seo, Hyemi Shin, Mijeong Lee, Sung Heon Kim, Yong-Jun Kwon, Jeong-Woo Oh, Minsuk Song, Misuk Kim, Doo-Sik Kong, Jung Won Choi, Ho Jun Seol, Jung-Il Lee, Seung Tae Kim, Joon Oh Park, Kyoung-Mee Kim, Sang-Yong Song, Jeong-Won Lee, Hee-Cheol Kim, Jeong Eon Lee, Min Gew Choi, Sung Wook Seo, Young Mog Shim, Jae Ill Zo, Byong Chang Jeong, Yeup Yoon, Gyu Ha Ryu, Nayoung K. D. Kim, Joon Seol Bae, Woong-Yang Park, Jeongwu Lee, Roel G. W. Verhaak, Antonio Iavarone, Jeeyun Lee, Raul Rabadan & Do-Hyun Nam. (2018) Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy. Nature Genetics 50:10, pages 1399-1411.
Crossref
Crossref
King Xin Koh, Gim Hwa Tan, Sarah Hong Hui Low, Mohd Feroz Mohd Omar, Min Ji Han, Barry Iacopetta, Ross Soo, Mounia Beloueche-Babari, Bhaskar Bhattacharya & Richie Soong. (2017) Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysis. Oncotarget 8:66, pages 110133-110144.
Crossref
Crossref
Kaoru Ishida, Chie Ito, Yukimi Ohmori, Kohei Kume, Kei A. Sato, Yuka Koizumi, Akari Konta, Takeshi Iwaya, Mamoru Nukatsuka, Takashi Kobunai, Teiji Takechi & Satoshi S. Nishizuka. (2017) Inhibition of PI3K suppresses propagation of drug-tolerant cancer cell subpopulations enriched by 5-fluorouracil. Scientific Reports 7:1.
Crossref
Crossref
Bhaskar Bhattacharya, Sarah Hong Hui Low, Mei Ling Chong, Dilys Chia, King Xin Koh, Nur Sabrina Sapari, Stanley Kaye, Huynh Hung, Touati Benoukraf & Richie Soong. (2016) Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer. Oncotarget 7:20, pages 29187-29198.
Crossref
Crossref
Chia-Ying Tsai, Mohit Kapoor, Ying-Pei Huang, Hui-Hsien Lin, Yu-Chuan Liang, Yu-Ling Lin, Su-Chin Huang, Wei-Neng Liao, Jen-Kun Chen, Jer-Shing Huang & Ming-Hua Hsu. (2016) Synthesis and Evaluation of Aminothiazole-Paeonol Derivatives as Potential Anticancer Agents. Molecules 21:2, pages 145.
Crossref
Crossref
Swarnendu TripathiLouiza BelkacemiMargaret S. CheungRathindra N. Bose. (2016) Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers. Cancer Informatics 15, pages CIN.S34506.
Crossref
Crossref
Michael Davidson, Alicia F.C. Okines & Naureen Starling. (2015) Current and Future Therapies for Advanced Gastric Cancer. Clinical Colorectal Cancer 14:4, pages 239-250.
Crossref
Crossref
Ismael Riquelme, Kathleen Saavedra, Jaime A. Espinoza, Helga Weber, Patricia García, Bruno Nervi, Marcelo Garrido, Alejandro H. Corvalán, Juan Carlos Roa & Carolina Bizama. (2015) Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget 6:28, pages 24750-24779.
Crossref
Crossref
Dan Yang, Jinglei Qu, Xiujuan Qu, Yubo Cao, Ling Xu, Kezuo Hou, Wanyu Feng & Yunpeng Liu. (2015) Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells. Cancer Chemotherapy and Pharmacology 76:3, pages 575-586.
Crossref
Crossref
Gulnaz T. Javan, Sheree J. Finley, Ismail Can, Amandeep Salhotra, Ashim Malhotra & Shivani Soni. 2015. Advanced Theranostic Materials. Advanced Theranostic Materials
1
35
.
Shikha Satendra Singh. (2015) Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?. World Journal of Gastroenterology 21:43, pages 12261.
Crossref
Crossref
Wei Yang, Alexander Raufi & Samuel J. Klempner. (2014) Targeted therapy for gastric cancer: Molecular pathways and ongoing investigations. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:1, pages 232-237.
Crossref
Crossref
Tasuku Matsuoka & Masakazu Yashiro. (2014) The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma. Cancers 6:3, pages 1441-1463.
Crossref
Crossref
B Bhattacharya, S H H Low, C Soh, N Kamal Mustapa, M Beloueche-Babari, K X Koh, J Loh & R Soong. (2014) Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype. British Journal of Pharmacology 171:13, pages 3255-3267.
Crossref
Crossref
Wenli Cui, Ying Cai & Xiaoyan Zhou. (2014) Advances in subunits of PI3K class I in cancer. Pathology 46:3, pages 169-176.
Crossref
Crossref
Maria Giovanna FrancipaneEric Lagasse. (2013) mTOR pathway in colorectal cancer: an update. Oncotarget 5:1, pages 49-66.
Crossref
Crossref
Jessica J. HowellStéphane J.H. RicoultIssam Ben-SahraBrendan D. Manning. (2013) A growing role for mTOR in promoting anabolic metabolism. Biochemical Society Transactions 41:4, pages 906-912.
Crossref
Crossref